Vitamin levels in Behcet's disease

被引:8
作者
Kandi, Basak [1 ]
Cicek, Demet
Ilhan, Nevin
机构
[1] Firat Univ, Fac Med, Dept Dermatol, TR-23119 Elazig, Turkey
[2] Firat Univ, Fac Med, Dept Clin Biochem, TR-23119 Elazig, Turkey
关键词
Behcet's disease; MDA; NO; vitamins;
D O I
10.1080/09546630601156355
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To determine the role of oxidative stress and the antioxidant defense mechanism in the etiopathogenesis of active and inactive Behcets disease. In line with this objective, the present study aimed to examine the levels of nitric oxide (NO) and malondialdehyde (MDA), which are the end products of oxidant stress, and vitamins, which are non-enzymatic antioxidants, for the diagnosis and particularly the follow-up of Behcet's disease. Materials and methods: The study group consisted of a total of 60 individuals: 40 of whom were Behcet's disease patients and 20 were healthy individuals. Of the 40 Behcet's patients, 29 had the active and 11 had the inactive (stable) form of the disease. Results: Although plasma MDA and NO (its stable form nitrite) levels in the total patient group were statistically significantly higher than those in the control group (p < 0.06), there was no statistically significant difference as such between inactive Behcet's patients and the control group (p > 0.05). Vitamin E, C, B1, B2 and flavin mononucleotide (FMN) values were significantly lower in the patient group in comparison with the control group (p < 0.05). There was no statistically significant difference in other vitamin values. Discussion: It is contemplated that measurement of such oxidative stress factors as MDA and NO and an accompanying evaluation of the antioxidant defense system can be significant in the diagnosis and treatment follow-up of Behcet's disease.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 46 条
[1]   Serum of patients with Behcet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro [J].
Alpsoy, E ;
Kodelja, V ;
Goerdt, S ;
Orfanos, CE ;
Zouboulis, CC .
DERMATOLOGY, 2003, 206 (03) :225-232
[2]  
Behçet H, 1937, DERMATOL WOCHENSCHR, V105, P1152
[3]   The evaluation of C-reactive protein, homocysteine and vitamin B6 concentrations in Behcet and rheumatoid arthritis disease [J].
Bekpinar, S ;
Koçak, H ;
Ünlüçerçi, Y ;
Genç, S ;
Akdag-Köse, A ;
Gögüs, F .
CLINICA CHIMICA ACTA, 2003, 329 (1-2) :143-145
[4]   Serum homocysteine level in Behcet's disease [J].
Çalikoglu, E ;
Öztas, M ;
Sengül, N ;
Adam, B ;
Gürer, MA .
HAEMATOLOGIA, 2002, 32 (03) :219-224
[5]  
Carletto A, 1997, J RHEUMATOL, V24, P1332
[6]   Behet's disease: infectious aetiology, new autoantigens, and HLA-B51 [J].
Direskeneli, H .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (11) :996-1002
[7]   Serum levels of vitamins A, C, and E, β-carotene, selenium, and zinc in patients with Behqet's disease -: A controlled study [J].
Erel, A ;
Özsoy, E ;
Biberoglu, G ;
Bilgihan, A ;
Hasanoglu, A ;
Yis, MO ;
Atahan, Ç ;
Oruk, S .
BIOLOGICAL TRACE ELEMENT RESEARCH, 2003, 95 (02) :97-105
[8]   Increased nitric oxide production in patients with Behcet's disease: Is it a new activity marker? [J].
Evereklioglu, C ;
Turkoz, Y ;
Er, H ;
Inaloz, HS ;
Ozbek, E ;
Cekmen, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (01) :50-54
[9]   Nitric oxide [J].
Farrell, AJ ;
Blake, DR .
ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (01) :7-20
[10]   Oxidative Stress in Adamantiades-Behcet's disease [J].
Freitas, JP ;
Filipe, P ;
Yousefi, A ;
Emerit, I ;
Rodrigo, FG .
DERMATOLOGY, 1998, 197 (04) :343-348